疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
. {2 m1 V; G% X6 q! Y: H
( k2 d& f- R- y0 v$ KSECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
' _0 T) Z$ E* {. K7 B9 I3 The vaccine industry 33
4 G" K, G# \& L9 T* t8 T4 Vaccine manufacturing 44
7 R$ u1 u8 g! ~: G5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
) q/ \/ B" D1 ~' V1 Z7 Passive immunization 80
/ @% Q' V/ g7 D, f8 General immunization practices 88
SECTION 2: Licensed vaccines
3 l8 m/ y( i$ c" E$ r9 Adenovirus vaccines 113
& L5 O8 H- b; m, _10 Anthrax vaccines 127
6 A7 H2 k( q, Z+ v) x0 c' l! g11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
6 Z% `, b9 r8 Z* R' w8 k/ j14 Hepatitis A vaccines 183
0 E3 {8 n, E$ [6 W6 v4 w/ J' v- [15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
# Z9 Q# ]( H5 K6 h18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
- n& }6 u0 |- }0 |% G+ t6 L- [20 Measles vaccines 352
# i  j- Q8 ~) g! P  J0 r21 Meningococcal vaccines 388
22 Mumps vaccine 419
! v3 K- y1 C4 K5 P, r* b6 m  V; w23 Pertussis vaccines . 447
# B7 {) Z( }2 w& u  s- w' ^24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
! N, r0 ^" d8 J& e7 M26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
, i! |- T$ s& N1 ~$ D5 G29 Rabies vaccines .646
6 f4 O% x3 i+ |4 z2 L0 O6 v30 Rotavirus vaccines . 669
) L( M) P0 n3 z' h! Q( z$ e! N31 Rubella vaccine 688
1 {9 i& U# ?: h3 `32 Smallpox and vaccinia 718
0 Z3 l% t3 c, o33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
% c8 {& x: }* v8 e+ r/ v% ^35 Tuberculosis vaccines 789
+ S9 A0 d% z2 W* G36 Typhoid fever vaccines 812
7 ^" d8 q) p5 G1 b37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
6 Q" N& L& g; O) DSECTION 3: Vaccines in development and new vaccine strategies
  n; b( {; {* X( M1 o$ C  W8 y" p41 Biodefense and special pathogen vaccines 1008
6 ^4 r! `  ^  n42 Therapeutic cancer vaccines 1018
" L. B0 l" ]9 q0 H4 R5 r/ ~43 Cytomegalovirus vaccines 1032
  {- i1 G) P3 n; W& r: I6 ?% [5 \44 Dengue vaccines 1042
9 g" H; U. |  j* x6 [1 _45 Diarrhea caused by bacteria 1052
6 r# G6 [! N7 o1 z7 \4 d46 Ebola vaccine 1060
) X  D1 I/ `0 }' R. V47 Epstein-Barr virus vaccines 1068
& v( A) q. {) v/ h1 U+ A48 Hepatitis C vaccines 1074
3 y! X  b9 J5 x; E/ X49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
' x& b* u+ R6 j, }0 L- l2 c51 Human immunodeficiency virus vaccines 1097
; l2 N, Z( B0 g. d) I( s# r+ o52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
* M* [9 p1 W# X9 R57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
8 ]/ m- Z4 @8 l2 T% o# \" r5 s9 G59 Streptococcus group B vaccines 1176
- _0 v! Z4 x0 o2 ?# |- O60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
8 v( y& a$ [& X4 f+ O7 PSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
+ j1 ^- z3 C* j8 V1 t5 V64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
. L& y: b8 d: I' r' R( ]SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
* _* l; w7 E7 ?6 H1 V! M69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
9 x" }3 O! j9 g% d* i71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
' y# n' g  w( i74 Regulation of vaccines in Europe 1447
9 Q% ?. X& w" t# _$ ^, D75 Regulation of vaccines in developing countries 1454
5 b; q" q0 I# x  C& q76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508
1 l, {  f/ `  m- H$ F* `6 ^
1 o, E0 i- K+ E  V+ H) P/ P

. ?4 `: F+ B) x! }$ O& F( t2 u

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

- Q' ^' n5 u: H0 t; ]$ F. D% lVaccines, 6th Edition
5 [  J) U/ _! Z$ X, g
: `( ~/ Z' U$ V# `! Y  N. f% MApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

1 M3 Q5 v# I: ]& p& ahttp://yun.baidu.com/share/link? ... 1&uk=3810996606
& e; @- |1 o7 J6 J8 ^$ d6 d
* `: K$ l& s3 X4 |: `9 y. }SECTION 1: General aspects of vaccination
5 D% x1 e. s$ t7 M4 A1 A short history of vaccination 1
1 i) [' q1 `0 p, ]' T( h1 _2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
* k2 Q1 k% s- N; i5 Evolution of adjuvants across the centuries 58
/ n6 T7 _4 _( f* k; H+ k8 B6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
/ L  z# X' b1 i6 q. f, [1 c, fSECTION 2: Licensed vaccines
- ^1 I: T/ Z& L! Q0 N9 Adenovirus vaccines 113
% `0 m( [' U' _9 E$ \' [10 Anthrax vaccines 127
  j: r, Y0 j/ n11 Cholera vaccines 141
12 Diphtheria toxoid 153
+ i. l& P! }. q2 J0 [( r13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
+ U. L1 N) J- `. m5 p15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
1 N% [0 J$ w6 R20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
+ T9 K8 s/ h1 Z, Z5 g( W$ c( S23 Pertussis vaccines . 447
24 Plague vaccines 493
; L6 ?& S# o, k5 o5 p* r25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
' w6 n; k. [6 o( I! [3 q  O26 Pneumococcal polysaccharide vaccines 542
) `* I% }( @+ }+ q1 M27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
- {2 R2 L9 r' z8 X29 Rabies vaccines .646
30 Rotavirus vaccines . 669
0 b7 J6 C+ X1 q. P$ m2 D31 Rubella vaccine 688
32 Smallpox and vaccinia 718
3 V4 \$ S4 O, Y; N& b' n33 Tetanus toxoid 746
$ e9 h, d* x0 ~; s5 u34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
3 w  ~' e- X' Z1 N: a36 Typhoid fever vaccines 812
) |9 I* k3 n* n) d- C: ~37 Varicella vaccine 837
38 Yellow fever vaccine 870
, P! a3 b% H# e- Q: J39 Zoster vaccine 969
4 T5 ]. Z# G7 f0 E4 l" R6 q40 Combination vaccines 981
+ E4 @1 `0 O0 X9 R/ @1 t* X4 CSECTION 3: Vaccines in development and new vaccine strategies
1 p' c' s/ q# u: Y% h( S: s( e$ ?41 Biodefense and special pathogen vaccines 1008
; D8 Q* Z" o: Y* Z2 _; A42 Therapeutic cancer vaccines 1018
6 r! r, T( f1 p9 Z1 o. O0 g% T43 Cytomegalovirus vaccines 1032
# y; Z; x2 \6 E) R0 L5 o* t1 O44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
9 q  T* Q0 k+ S. @% l* y& L& x47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
' h2 P& T. P+ V" u49 Hepatitis E vaccines 1085
& O! C9 P7 M3 W3 y0 h50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
4 ?- V1 t7 W! \( {52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
( l: U. {: y8 X2 R54 Noninfectious disease vaccines 1138
7 I2 U% l  M( Z& G55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
/ E& r+ f  B) \, h56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
7 w2 O/ j% W+ Z0 ~! r58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
" d( }7 i9 `6 v  X6 D: Y61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
4 ]2 B# e. m1 Q# W5 o63 Vaccination of immunocompromised hosts 1243
  `; S0 S1 G: c% K4 f% H. R64 Vaccination of human immunodeficiency virus-infected persons 1257
: B# _% P3 j3 h: G65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
! n+ h1 D0 ~8 \& e$ \, YSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
; f% p9 O! K9 I. i# M69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
9 o/ h, C2 H" j! l6 y8 R71 Community immunity 1395
1 X# l" l6 P% s. q1 z' D72 Economic analyses of vaccine policies 1413
5 F" E6 f) f# V; i2 S/ W73 Regulation and testing of vaccines 1427
5 A, j3 N( C7 t4 A/ _74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
4 e1 ~! f$ b1 O77 Legal issues . 1481
78 Ethics 1508
3 ]9 F) k. O9 @( J5 O$ R; k1 I$ c

/ r. T. a! {' [9 M: ]

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
  K- ]2 s( \& L1 i0 eLanguage: English
% z* f! c  Y! MISBN-10: 1455700908
+ K$ Y8 p& z: l$ j. xSize: 52.3mb (original pdf)
0 p! @- g7 V: V1 b0 e: B
  W- H  f% Y2 i5 A( X6 q2013 BMA Medical Book Awards Highly Commended in Public Health!
! S: _. r8 ]0 d7 C$ U) ZApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
" m- b* x* o! Z/ K
/ P) [3 s7 m" R1 hGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
9 g0 {# q  L# I& n8 d& @0 ]3 EAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
( {7 V* T* v- W% HStay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
+ r/ \. E; n. x# z3 l) L
7 r# n2 Y4 S  t7 _5 E9 i2 ^% {7 WDownload link: http://pan.baidu.com/s/1i5NxwLR
; r5 H  @8 l8 p! `8 G- }! pCode for downloading: dv96